IL-17A, IL-17E and IL-17F as Potential Biomarkers for the Intensity of Low-Grade Inflammation and the Risk of Cardiovascular Diseases in Obese People

Low-grade inflammation is a factor that predisposes to many obesity-related comorbidities. The immune mechanisms controlling the inflammatory response related to the secretory activity of adipocytes and its consequences for the organism are still under investigation. Methods: 84 obese adult volunteers (BMI ≥ 30 kg/m2) were tested by BIA. Serum samples were collected to analyze the concentrations of interleukins IL-17A, IL-17E and IL-17F. The subjects completed the original questionnaire, the FFQ-6 food consumption frequency questionnaire and the food diary. Results: The level of IL-17E and IL-17F was positively correlated with the BMI value and the level of IL-17E increased with the content of subcutaneous fat. Its increased blood concentration was also observed in individuals who declared that they were diagnosed with atherosclerosis and/or were taking beta-blockers. Products that were related with a low level of the above-mentioned interleukins were vegetables, groats, eggs, red meat, fast-food and alcohol. The level of these interleukins was positively correlated with the frequent consumption of confectionery and breakfast cereals. Nutrients that decreased the concentrations of IL-17 isoforms were potassium, iron, vitamins B6 and C, and folic acid. Conclusions: Both IL-17E and IL-17F may be closely related to the intensity of low-grade inflammation and be biomarkers of cardiovascular disease risk. Food products or the nutrients they contain may affect the levels of the above-mentioned interleukins as well as IL-17A.

[1]  Yonas Akalu,et al.  Effect of Leptin on Chronic Inflammatory Disorders: Insights to Therapeutic Target to Prevent Further Cardiovascular Complication , 2021, Diabetes, metabolic syndrome and obesity : targets and therapy.

[2]  A. Menter,et al.  Interleukin-17 and Interleukin-23: A Narrative Review of Mechanisms of Action in Psoriasis and Associated Comorbidities , 2021, Dermatology and Therapy.

[3]  W. Boehncke,et al.  IL-25 (IL-17E) in epithelial immunology and pathophysiology. , 2021, The Journal of allergy and clinical immunology.

[4]  M. Grioni,et al.  Much More Than IL-17A: Cytokines of the IL-17 Family Between Microbiota and Cancer , 2020, Frontiers in Immunology.

[5]  A. Lawson,et al.  Bimekizumab, a Novel Humanized IgG1 Antibody That Neutralizes Both IL-17A and IL-17F , 2020, Frontiers in Immunology.

[6]  W. Boehncke,et al.  IL-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications , 2020, Frontiers in Immunology.

[7]  S. Gaffen,et al.  The IL-17 Family of Cytokines in Health and Disease. , 2019, Immunity.

[8]  H. Marzo-Ortega,et al.  The advent of IL-17A blockade in ankylosing spondylitis: secukinumab, ixekizumab and beyond , 2019, Expert review of clinical immunology.

[9]  Receptors and Signaling , 2018, Progress, Pioneers and Process.

[10]  A. Blauvelt,et al.  The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis , 2018, Clinical Reviews in Allergy & Immunology.

[11]  W. Drygas,et al.  Dietary acid load and cardiometabolic risk in the Polish adult population. , 2018, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

[12]  W. Boehncke,et al.  The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond , 2018, Front. Immunol..

[13]  F. Shahidi,et al.  Bioactivities of Phenolics by Focusing on Suppression of Chronic Diseases: A Review , 2018, International journal of molecular sciences.

[14]  Baojun Xu,et al.  Anti-inflammatory effects of phytochemicals from fruits, vegetables, and food legumes: A review , 2018, Critical reviews in food science and nutrition.

[15]  A. Lawson,et al.  Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation , 2017, Annals of the rheumatic diseases.

[16]  H. Vidal,et al.  Pathogenic Role of IL-17-Producing Immune Cells in Obesity, and Related Inflammatory Diseases , 2017, Journal of clinical medicine.

[17]  M. Blüher,et al.  Free fatty acids sensitize dendritic cells to amplify TH1/TH17‐immune responses , 2016, European journal of immunology.

[18]  P. G. Raman,et al.  Environmental Factors in Causation of Diabetes Mellitus , 2016 .

[19]  T. Morgan,et al.  A Diet Mimicking Fasting Promotes Regeneration and Reduces Autoimmunity and Multiple Sclerosis Symptoms. , 2016, Cell reports.

[20]  A. Goto,et al.  High Dietary Acid Load Score Is Associated with Increased Risk of Type 2 Diabetes in Japanese Men: The Japan Public Health Center-based Prospective Study. , 2016, The Journal of nutrition.

[21]  Hongbing Wang,et al.  IL-25 or IL-17E Protects against High-Fat Diet–Induced Hepatic Steatosis in Mice Dependent upon IL-13 Activation of STAT6 , 2015, The Journal of Immunology.

[22]  J. Alcorn,et al.  Diet, interleukin-17, and childhood asthma in Puerto Ricans. , 2015, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[23]  C. Andersen Bioactive Egg Components and Inflammation , 2015, Nutrients.

[24]  Steve Nelson,et al.  Ethanol Impairs Mucosal Immunity against Streptococcus pneumoniae Infection by Disrupting Interleukin 17 Gene Expression , 2015, Infection and Immunity.

[25]  A. Dent,et al.  MicroRNA 21 Is a Homeostatic Regulator of Macrophage Polarization and Prevents Prostaglandin E2-Mediated M2 Generation , 2015, PloS one.

[26]  Y. Mine,et al.  Oral administration of hen egg white ovotransferrin attenuates the development of colitis induced by dextran sodium sulfate in mice. , 2015, Journal of agricultural and food chemistry.

[27]  J. Ärnlöv,et al.  Dietary acid load, insulin sensitivity and risk of type 2 diabetes in community-dwelling older men , 2014, Diabetologia.

[28]  K. Clément,et al.  T Cell–Derived IL-22 Amplifies IL-1β–Driven Inflammation in Human Adipose Tissue: Relevance to Obesity and Type 2 Diabetes , 2014, Diabetes.

[29]  Rohit Kohli,et al.  IL-17 Signaling Accelerates the Progression of Nonalcoholic Fatty Liver Disease in Mice , 2014, Hepatology.

[30]  L. Robinson,et al.  Cooked navy and black bean diets improve biomarkers of colon health and reduce inflammation during colitis , 2014, British Journal of Nutrition.

[31]  Beverley Balkau,et al.  Dietary acid load and risk of type 2 diabetes: the E3N-EPIC cohort study , 2014, Diabetologia.

[32]  C. Gu,et al.  IL-17 family: cytokines, receptors and signaling. , 2013, Cytokine.

[33]  J. Gugenheim,et al.  Identification of Adipose Tissue Dendritic Cells Correlated With Obesity-Associated Insulin-Resistance and Inducing Th17 Responses in Mice and Patients , 2012, Diabetes.

[34]  E. Finkelstein,et al.  Obesity and severe obesity forecasts through 2030. , 2012, American journal of preventive medicine.

[35]  H. Chi,et al.  Regulation of TH17 cell differentiation by innate immune signals , 2012, Cellular and Molecular Immunology.

[36]  P. Voulgari,et al.  Obesity, adipose tissue and rheumatoid arthritis: coincidence or more complex relationship? , 2011, Clinical and experimental rheumatology.

[37]  J. Knight Diseases and disorders associated with excess body weight. , 2011, Annals of clinical and laboratory science.

[38]  E. Butcher,et al.  IL-17 Regulates Adipogenesis, Glucose Homeostasis, and Obesity , 2010, The Journal of Immunology.

[39]  S. Gaffen,et al.  IL-17 in obesity and adipogenesis. , 2010, Cytokine & growth factor reviews.

[40]  G. Tsokos,et al.  IL-17 in Systemic Lupus Erythematosus , 2010, Journal of biomedicine & biotechnology.

[41]  G. Fantuzzi,et al.  Enhanced production of IL‐17A during zymosan‐induced peritonitis in obese mice , 2010, Journal of leukocyte biology.

[42]  E. Engleman,et al.  Obesity predisposes to Th17 bias , 2009, European journal of immunology.

[43]  C. Dong,et al.  IL-17F: regulation, signaling and function in inflammation. , 2009, Cytokine.

[44]  Y. Mine,et al.  Hen egg lysozyme attenuates inflammation and modulates local gene expression in a porcine model of dextran sodium sulfate (DSS)-induced colitis. , 2009, Journal of agricultural and food chemistry.

[45]  L. Garrett-Sinha,et al.  IL-17 and the Th17 lineage in systemic lupus erythematosus , 2008, Current opinion in rheumatology.

[46]  G. Fantuzzi,et al.  Role and regulation of adipokines during zymosan-induced peritoneal inflammation in mice. , 2008, Endocrinology.

[47]  E. Lubberts,et al.  IL-17/Th17 targeting: on the road to prevent chronic destructive arthritis? , 2008, Cytokine.

[48]  T. Mcclanahan,et al.  IL-23 promotes tumour incidence and growth , 2006, Nature.

[49]  G. Fantuzzi Adipose tissue, adipokines, and inflammation. , 2005, The Journal of allergy and clinical immunology.

[50]  A. Lindén,et al.  Interleukin-17 family members and inflammation. , 2004, Immunity.

[51]  M. Lotze,et al.  Interleukin-17 promotes angiogenesis and tumor growth. , 2003, Blood.

[52]  E. Gunter,et al.  The effects of iron deficiency on lymphocyte cytokine production and activation: preservation of hepatic iron but not at all cost , 2001, Clinical and experimental immunology.

[53]  J. Shellito,et al.  Effect of alcohol consumption on host release of interleukin-17 during pulmonary infection with Klebsiella pneumoniae. , 2001, Alcoholism, clinical and experimental research.

[54]  M. Serafini,et al.  High fat meal increase of IL-17 is prevented by ingestion of fruit juice drink in healthy overweight subjects. , 2012, Current pharmaceutical design.

[55]  S. Nelson,et al.  Alcohol, immunosuppression, and the lung. , 2005, Proceedings of the American Thoracic Society.